Rani Therapeutics Receives Feedback From Pre-IND FDA Meeting; Provides Pipeline Update
Pipeline Updates:
Preliminary feedback received from the FDA on future development of RT-102. Following feedback from a pre-IND meeting with the FDA, Rani believes that a 505(b)(2) pathway is suitable for the
